HIGHLIGHTS
- who: Nicolas from the , Paris, France have published the research work: Low-dose interleukin-2 shapes a tolerogenic gut microbiota that improves autoimmunity and gut inflammation, in the Journal: (JOURNAL)
SUMMARY
Low-dose interleukin-2 shapes a tolerogenic gut microbiota that improves autoimmunity and gut inflammation. Nicolas Tchitchek1, Otriv Nguekap Tchoumba1,2†, Gabriel Pires1†, Sarah Dandou1, Julien Campagne1, Guillaume Churlaud1,2, Gwladys Fourcade1, Thomas W. Hoffmann3, Francesco Strozzi4, Camille Gaal4, Christophe Bonny4, Emmanuelle Le Chatelier5, Dusko Erlich5, Harry Sokol3,6,7 and David Klatzmann1,2* 75005 Paris, France. Sorbonne Université, INSERM, Immunology-Immunopathology . . .
If you want to have access to all the content you need to log in!
Thanks :)
If you don't have an account, you can create one here.